Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LUSPATERCEPT Cause Blood creatinine increased? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Blood creatinine increased have been filed in association with LUSPATERCEPT (Reblozyl). This represents 1.9% of all adverse event reports for LUSPATERCEPT.

5
Reports of Blood creatinine increased with LUSPATERCEPT
1.9%
of all LUSPATERCEPT reports
0
Deaths
1
Hospitalizations

How Dangerous Is Blood creatinine increased From LUSPATERCEPT?

Of the 5 reports, 1 (20.0%) required hospitalization.

Is Blood creatinine increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LUSPATERCEPT. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does LUSPATERCEPT Cause?

Death (16) Off label use (12) Fatigue (11) Anaemia (10) Extramedullary haemopoiesis (10) Pneumonia (10) Drug ineffective (9) Haemoglobin decreased (9) Thrombocytopenia (9) Cerebrovascular accident (8)

What Other Drugs Cause Blood creatinine increased?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,966) TENOFOVIR DISOPROXIL (1,460) TACROLIMUS (1,439) METHOTREXATE (1,401) SACUBITRIL\VALSARTAN (1,389) RITUXIMAB (1,265) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,112) METFORMIN (986) ECULIZUMAB (967) LENALIDOMIDE (959)

Which LUSPATERCEPT Alternatives Have Lower Blood creatinine increased Risk?

LUSPATERCEPT vs LUSPATERCEPT-AAMT LUSPATERCEPT vs LUTEIN LUSPATERCEPT vs LUTETIUM LU-177 LUSPATERCEPT vs LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN LUSPATERCEPT vs LUTETIUM OXODOTREOTIDE LU-177

Related Pages

LUSPATERCEPT Full Profile All Blood creatinine increased Reports All Drugs Causing Blood creatinine increased LUSPATERCEPT Demographics